InvestorsHub Logo
Followers 7
Posts 564
Boards Moderated 0
Alias Born 08/27/2014

Re: Biobillionair post# 168968

Wednesday, 12/26/2018 3:08:24 PM

Wednesday, December 26, 2018 3:08:24 PM

Post# of 425931
BB...you could always compare your earnings model with Jeffriies...would love to see the differences if you were willing to share!

Amarin Co. plc (NASDAQ:AMRN) – Equities researchers at Jefferies Financial Group dropped their FY2018 earnings per share estimates for Amarin in a report released on Wednesday, December 19th. Jefferies Financial Group analyst M. Yee now forecasts that the biopharmaceutical company will post earnings per share of ($0.41) for the year, down from their prior estimate of ($0.34). Jefferies Financial Group has a “Buy” rating and a $30.00 price target on the stock. Jefferies Financial Group also issued estimates for Amarin’s Q4 2018 earnings at ($0.12) EPS, Q1 2019 earnings at ($0.12) EPS, Q2 2019 earnings at ($0.10) EPS, Q3 2019 earnings at ($0.10) EPS, Q4 2019 earnings at ($0.10) EPS, FY2019 earnings at ($0.42) EPS and FY2020 earnings at ($0.13) EPS.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News